{
  "nctId": "NCT07175311",
  "briefTitle": "Vascular Changes Associated With Endophthalmitis.",
  "officialTitle": "Vascular Changes Associated With Endophthalmitis.",
  "protocolDocument": {
    "nctId": "NCT07175311",
    "filename": "Prot_000.pdf",
    "label": "Study Protocol",
    "date": "2024-11-01",
    "uploadDate": "2025-09-09T14:46",
    "size": 384589,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT07175311/document/Prot_000.pdf",
    "hasProtocol": true,
    "hasSap": false,
    "hasIcf": false
  },
  "phase": [],
  "studyType": "OBSERVATIONAL",
  "enrollmentInfo": {
    "enrollmentCount": 71,
    "enrollmentType": "ESTIMATED"
  },
  "timeline": {
    "startDate": "2024-11-01",
    "completionDate": "2026-03-01",
    "primaryCompletionDate": "2026-02",
    "firstSubmitDate": "2025-07-29",
    "firstPostDate": "2025-09-16"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Patients with a history of endophthalmitis Diagnosis of Endophthalmitis\n* Clinical symptoms: Pain, decrease in visual acuity, anterior chamber cells and/or vitreous turbidity, corneal edema, conjunctival hyperemia\n* Laboratory studies: B-mode USG and or positive culture\n* Patients who meet the endophthalmitis resolution criteria of the Mexican Endophthalmitis Study Group\n* Patients with previously signed informed consent\n\nExclusion Criteria:\n\n* Patients who have not signed the informed consent\n* Patients under 18 years.\n* Patients with endophthalmitis who do not meet the resolution criteria of the Mexican Endophthalmitis Study Group",
    "healthyVolunteers": true,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Best-Corrected Visual Acuity (BCVA)",
        "description": "Best-Corrected Visual Acuity (BCVA) will be assessed according to the ETDRS guidelines. The test must be performed with the patient positioned 4 meters from the backlit panel, which must be calibrated to emit 85 cd/m². This procedure will be carried out by the retina fellow assigned to the case.",
        "timeFrame": "The assessment will be performed at each visit (7 days and 1 month after meeting the inactivation criteria for endophthalmitis)."
      }
    ],
    "secondary": [
      {
        "measure": "Fluorescein Angiography",
        "description": "Fluorescein angiography will be performed subsequently to evaluate associated vascular changes. The patient must undergo an 8-hour fast and have pupillary dilation with TP Ofteno® (tropicamide 5% / phenylephrine 0.8%). The procedure involves preparing the patient with aseptic technique for an intravenous injection of fluorescein dye in an upper limb, followed by imaging with a fundus camera. It is not essential to use a device of a specific brand or model, as long as a system with equivalent specifications is used consistently for the same patient throughout the study. A technician or delegated personnel may perform the procedure.",
        "timeFrame": "The procedure may be performed at all study visits (7 days and 1 month after meeting the inactivation criteria for endophthalmitis)."
      },
      {
        "measure": "Fundus Photography",
        "description": "Fundus imaging will be performed using the Clarus 700 Zeiss, Serial #CL700-73467, Software version 1.1.2.59261, Digital Camera Magnification 133°. Images of the posterior pole and retinal periphery will be captured, providing a comprehensive view of retinal integrity, the optic nerve, and its vasculature.",
        "timeFrame": "The procedure may be performed at all study visits (7 days and 1 month after meeting the inactivation criteria for endophthalmitis)."
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 0,
      "exclusionCount": 0,
      "totalCount": 0
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 2,
      "otherCount": 0,
      "totalCount": 3
    },
    "studyDesign": {
      "phases": [],
      "isRandomized": false,
      "isMasked": true
    },
    "overallComplexityScore": 35,
    "complexityCategory": "Moderate"
  },
  "collectionDate": "2025-09-22T05:06:11.775Z",
  "dataSource": "ClinicalTrials.gov API v2 - Ultimate Complete Collection"
}